18th Annual Report of the Company for the financial year 2024-25 in Compliance with SEBI (LODR) Regulations, 2015 is attached herewith.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hamps Bio Limited, a Gujarat-based manufacturer and exporter of freeze-dried fruits, vegetables, and wellness ingredients, has submitted its 18th Annual Report for FY 2024-25. Revenue rose modestly to Rs. 6.67 crore (from Rs. 6.48 crore in FY24), while net profit dipped to Rs. 29.77 lakh (from Rs. 50.06 lakh) due to investments in the new Surat facility. The company recently listed on the BSE SME platform in December 2024 after a successful IPO of 12.2 lakh shares at Rs. 51 each. Commercial production at the new Surat (Bhatpore) freeze-drying plant began on 1 April 2025, taking total capacity to 78 tonnes/month, and a 350 kVA solar plant has been installed at the Ankleshwar unit. The Board has proposed a 1:1 bonus share issue (capitalising up to Rs. 4.36 crore from free reserves), an increase in authorised share capital from Rs. 5 crore to Rs. 10 crore, and appointment of Richa Goyal & Associates as Secretarial Auditor for FY26–FY30. The 18th AGM is scheduled for Saturday, 30 August 2025 at Ankleshwar.
Mixed near-term signal — modest revenue growth and profit dip due to expansion spending, but a new plant coming online, 30% revenue/export growth guidance, bonus shares, and sustainability investments are positive for long-term shareholder value. Shareholders should watch the AGM outcome on bonus issue and share capital expansion.